INARI MEDICAL INC (NARI)
US45332Y1091 - Common Stock
First Week of January 2025 Options Trading For Inari Medical (NARI)
Inari Medical to Participate in the Jefferies London Healthcare Conference
Inari Medical Breaks Above 200-Day Moving Average - Bullish for NARI
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization
Inari Medical Reports Third Quarter 2024 Financial Results
Inari Medical Reports Third Quarter 2024 Financial Results
IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
Okami Medical Announces Closing Of $32.5M Financing
/PRNewswire/ -- Okami Medical today announced the closing of a $32.5M financing led by new investor Vensana Capital and joined by existing investors including...
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
Inari Medical to Announce Third Quarter 2024 Financial Results
Inari Medical to Announce Third Quarter 2024 Financial Results
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
Inari Medical is Now Oversold (NARI)
Inari Medical Becomes Oversold (NARI)
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
Inari Medical to Present at Upcoming Investor Conferences
Inari Medical to Present at Upcoming Investor Conferences
IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
7 Leading MedTech Stocks for Next-Gen Health Solutions
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q2 2024
NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Inari Medical (NASDAQ:NARI) just reported results for the second quarter of 202...
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
Mitch Hill to retire as Chief Financial Officer, to be succeeded by Kevin Strange in October 2024
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
Mitch Hill to retire as Chief Financial Officer, to be succeeded by Kevin Strange in October 2024...
Inari Medical Reports Second Quarter 2024 Financial Results
Inari Medical Reports Second Quarter 2024 Financial Results
IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
Inari Medical to Announce Second Quarter 2024 Financial Results
Inari Medical to Announce Second Quarter 2024 Financial Results
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inari To Contact Him Directly To Discuss Their Options
Investors who lost money on Inari Medical, Inc.(NARI) should contact The Gross Law Firm about pending Class Action - NARI
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI...